** Shares of drugmaker ANI Pharmaceuticals ANIP.O rise 1.5% to $72.60

** Raises 2025 per-share profit forecast to between $6.27 and $6.62, compared with between $6.12 and $6.49 earlier

** Expects full-year revenue of $768 million-$793 million, compared with previously projected $756 million-$776 million

** Quarterly revenue jumped 43.4% to $197.1 million, above analysts' estimates of $180.68 million - data compiled by LSEG

** Including session's moves, stock up 33% YTD

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))